The blue copper ceruloplasmin induces aggregation of newly differentiated neurons: A potential modulator of nervous system organization

Neuroscience

Volumn 121, Issue 1, 2003, Pages 73-82

  Maltais, D ^a   Desroches, D ^a   Aouffen, M ^a   Mateescu, M A ^a   Wang, R ^b   Paquin, J ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Binding receptor sites; Mouse embryonal carcinoma; Nervous system development; Neuronal migration adhesion; Neuropeptide secretion; Patch clamp

Indexed keywords

CERULOPLASMIN; COPPER DERIVATIVE; COPPER PROTEIN; DIGOXIGENIN; HISTIDINE DERIVATIVE; POTASSIUM CHANNEL;

AGING; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL AGGREGATION; CELL DEATH; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; INFLAMMATION; IRON METABOLISM; MOUSE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION;

EID: 0142123579     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00325-7     Document Type: Article

References (55)

1. Aouffen M., Paquin J., De Grandpré E., Nadeau R., Mateescu M.-A. Deglycosylated ceruloplasmin maintains its enzymatic, antioxidant, cardioprotective and neuronoprotective properties. Biochem Cell Biol. 79:2001;489-497.
2. Atanasiu R., Chahine R., Mateescu M., Nadeau R. The antiarrhythmic effects of ceruloplasmin during reperfusion in the ischemic isolated rat heart. Can J Physiol Pharmacol. 73:1995;1253-1261.
3. Atanasiu R., Gouin L., Mateescu M.-A., Cardinal R., Nadeau R. Class III antiarrhythmic effects of ceruloplasmin on rat heart. Can J Physiol Pharmacol. 74:1996;652-656.
4. Atanasiu R.L., Stea D., Mateescu M.-A., Vergely C., Dalloz F., Briot F., Maupoil V., Nadeau R., Rochette L. Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem. 189:1998;127-135.
5. Averill-Bates D.A., Agostinelli E., Przybytkowski E., Mateescu M.-A., Mondovi B. Cytotoxicity and kinetic analysis of purified bovine serum amine oxidase in the presence of spermine in Chinese hamster ovary cells. Arch Biochem Biophys. 300:1993;75-79.
6. Barnes G., Frieden E. Ceruloplasmin receptors of erythrocytes. Biochem Biophys Res Commun. 125:1984;157-162.
7. Boivin S., Aouffen M., Fournier A., Mateescu M.A. Molecular characterization of human and bovine ceruloplasmin using MALDI-TOF mass spectrometry. Biochem Biophys Res Commun. 288:2001;1006-1010.
8. Bowman B.H. Hepatic plasma proteins mechanisms of function and regulation . 1993;Academic Press Inc, San Diego, CA.
9. Broadley C., Hoover R.L. Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells. Am J Pathol. 135:1989;647-655.
10. Cadet N., Paquin J. Conversion and storage of somatostatine are established before response to secretagogue stimuli in P19 neurons. Dev Brain Res. 120:2000;211-221.
11. Calabrese L., Malatesta F., Barra D. Purification and properties of bovine ceruloplasmin. Biochem Int. 199:1981;667-673.
12. Chahine R., Mateescu M.-A., Roger S., Yamaguchi N., de Champlain J., Nadeau R. Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart. Can J Physiol Pharmacol. 69:1991;1459-1464.
13. Curtis A.S.G., Forrester J.V. The competitive effects of serum proteins on cell adhesion. J Cell Sci. 71:1984;17-35.
14. Dameron C.T., Harris E.D. Regulation of aortic CuZn-superoxide dismutase with copper caeruloplasmin and albumin reactivate and transfer copper to the enzyme in culture . Biochem J. 248:1987;663-675.
15. David, S, Patel, BN (2000) Ceruloplasmin: structure and function of an essential ferroxidase. In: Advances in structural biology, Vol. 6 (Malhotra SK, ed), pp 211-237. New York: JAI Press Inc.
16. Dumoulin M.-J., Chahine R., Atanasiu R., Nadeau R., Mateescu M.-A. Comparative antioxidant and cardioprotective effects of ceruloplasmin, superoxide dismutase and albumin. Arzneimittel-Forsch Drug Res. 46:1996;855-861.
17. Finley M.F., Kulkarni N., Huettner J.E. Synapse formation and establishment of neuronal polarity by P19 embryonic carcinoma cells and embryonic stem cells. J Neurosci. 16:1996;1056-1065.
18. Goldstein I.M., Kaplan H.B., Edelson H.S., Weissmann G. Ceruloplasmin an acute phase reactant that scavenges oxygen-derived free radicals . Ann NY Acad Sci. 92:1982;360-369.
19. Haïdara K., Moffatt P., Denizeau F. Metallothionein induction attenuates the effects of glutathione depletors in rat hepatocytes. Toxicol Sci. 49:1999;297-305.
20. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T.A., Gitlin J.D. Aceruloplasminemia molecular characterization of this disorder of iron metabolism . Proc Natl Acad Sci USA. 92:1995;2539-2543.
21. Harris Z.L., Durley A.P., Man T.K., Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA. 96:1999;10812-10817.
22. Hartard C., Weisner B., Dieu C., Kunze K. Wilson's disease with cerebral manifestation monitoring therapy by CSF copper concentration . J Neurol. 241:1993;101-107.
23. Hartmann H.A., Evenson M.A. Deficiency of copper can cause neuronal degeneration. Med Hypothesis. 378:1992;75-85.
24. Hatten M.E. Central nervous system neuronal migration. Annu Rev Neurosci. 22:1999;511-539.
25. Hilton M., Spencer D.C., Ross P., Ramsey A., McArdle H.J. Characterization of the copper uptake mechanism and isolation of the ceruloplasmin receptor/copper transporter in human placental vesicles. Biochim Biophys Acta. 1245:1995;153-160.
26. Honig L.S., Rosenberg M.D. Apoptosis and neurologic disease. Am J Med. 108:2000;317-330.
27. Jeannotte R., Paquin J., Petit-Turcotte C., Day R. Convertase PC2 and the neuroendocrine polypeptide 7B2 are co-induced and processed during neuronal differentiation of P19 embryonal carcinoma cells. DNA Cell Biol. 16:1997;1175-1187.
28. Kataoka M., Tavassoli M. Identification of ceruloplasmin receptors on the surface of human blood monocytes, granulocytes, and lymphocytes. Exp Hematol. 13:1985;806-810.
29. Katz B.M., Barnea A. The ligand specificity for uptake of complexed copper-67 by brain hypothalamic tissue is a function of copper concentration and copper ligand molar ratio . J Biol Chem. 265:1990;2017-2021.
30. Klomp L.W., Gitlin J.D. Expression of the ceruloplasmin gene in the human retina and brain implications for a pathogenic model in aceruloplasminemia . Hum Mol Genet. 5:1996;1989-1996.
31. MacPherson P.A., McBurney M.W. Pig embryonal carcinoma cells a source of cultured neurons amenable to genetic manipulation . Methods: A Companion to Methods in Enzymology. 7:1995;238-252.
32. MacPherson P.A., Jones S., Pawson P.A., Marshall K.C., McBurney M.W. P19 cells differentiate into glutamatergic and glutamate-responsive neurons in vitro. Neuroscience. 80:1997;487-499.
33. Mateescu M., Chahine R., Roger S., Atanasiu R., Yamaguchi N., Lalumière G., Nadeau R. Protection of myocardial tissue against deleterious effects of oxygen free radicals by ceruloplasmin. Arzneimittel-Forsch Drug Res. 45:1995;476-480.
34. Mateescu M.-A., Wang X.T., Dumoulin M.-J., Befani O., Mondovi B. Simultaneous chromatographic separation of ceruloplasmin and serum amine oxidase. Aboul-Enein H.Y. Analytical and preparative separation methods of biomacromolecules. 1999;445-455 Marcel Dekker Inc, New York.
35. McAuslan B.R., Reily W.G., Hannan G.N., Gole G.A. Angiogenic factors and their assay activity of formyl methionyl leucyl phenylalanine, adenosine diphosphate, heparin, copper and bovine endothelium stimulating factor . Microvasc Res. 26:1983;323-338.
36. McBurney M.W. P19 embryonal carcinoma cells. Int J Dev Biol. 37:1993;135-140.
37. Messerschmidt A., Huber R. The blue oxidases ascorbate oxidase, laccase and ceruloplasmin modelling and structural relationships . Eur J Biochem. 187:1990;341-352.
38. Mollgard K., Dziegielewska K.M., Saunders N.R., Zakut H., Soreq H. Synthesis and localization of plasma proteins in the developing human brain integrity of the fetal blood-brain barrier to endogenous proteins of hepatic origin . Dev Biol. 128:1988;207-221.
39. Mukhopadhyay C.K., Attieh Z.H., Fox P.L. Role of ceruloplasmin in cellular iron uptake. Science. 279:1998;714-717.
40. Orena S.J., Goode C.A., Linder M.C. Binding and uptake of copper from ceruloplasmin. Biochem Biophys Res Commun. 139:1986;822-829.
41. Parnas D., Linial M. Acceleration of neuronal maturation of P19 cells by increasing culture density. Dev Brain Res. 101:1997;115-124.
42. Patel B.N., David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem. 272:1997;20185-20190.
43. Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.-P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci. 22:2002;6578-6586.
44. Puchkova L.V., Sasina L.K., Aleinikova T.D., Zakharova E.T., Gaitskhoki V.S. Reconstitution of the intercellular transfer pathway of the peptide moiety of ceruloplasmin in mammals. Biochemistry (Moscow). 62:1997;697-703.
45. Qian Z.M., Ke Y. Rethinking the role of ceruloplasmin in brain iron metabolism. Brain Res Rev. 35:2001;287-294.
46. Salzer J.L., Lovejoy L., Linder M.C., Rosen C. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J Neurosci Res. 54:1998;147-157.
47. Sarkar B., Lingertat-Walsh K., Clarke J.T.R. Copper-histidine therapy for Menkes disease. J Pediatr. 123:1993;828-830.
48. Skerjanc I.S. Cardiac and skeletal muscle development in P19 embryonal carcinoma cells. Trends Cardiovasc Med. 9:1999;139-143.
49. Staines W.A., Morassutti D.J., Reuhl K.R., Ally A., McBurney M.W. Neurons derived from P19 embryonal carcinoma cells have varied morphologies and neurotransmitters. Neuroscience. 58:1994;735-751.
50. Stevens M.O., Di Silvestro R.A., Harris E.D. Specific receptors for ceruloplasmin in membrane fragments from aortic and heart tissues. Biochemistry. 23:1984;261-266.
51. Waggoner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol Dis. 6:1999;221-230.
52. Wang R., Zhang L., Mateescu M.-A., Nadeau R. Ceruloplasmin an endogenous depolarizing factor in neurons? Biochem Biophys Res Commun. 207:1995;599-605.
53. + channel by serum amineoxidase in neurons. Biochem Biophys Res Commun. 220:1996;47-52.
54. Yoshida S., Shiosaka S. Plasticity-related serine proteases in the brain. Int J Mol Med. 3:1999;405-409.
55. Zaitseva I., Zaitsev V., Card G., Moshkov K., Bax B., Ralph A., Lindley P. The X-ray structure of human serum ceruloplasmin at 3.1 Å nature of the copper centres . J Biol Inorg Chem. 1:1996;15-23.